Position history for STIFEL FINANCIAL CORP's holdings in BIOCRYST PHARMACEUTICALS INC
STIFEL FINANCIAL CORP holds 1.8M shares of BCRX (BIOCRYST PHARMACEUTICALS INC), worth $17.4M as of 2026-Q1. The position was increased (+0.0% shares). BCRX represents 0.0% of STIFEL FINANCIAL CORP's portfolio.
Current Value
$17.4M
Current Shares
1.8M
Total Value Change
+$6M
Total Shares Change
-18,468
Other major holders of BCRX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BNP PARIBAS FINANCIAL MARKETS
Increased |
| 1.8M |
+0.0% |
| $17.4M |
| 0.0% |
| $8.69 |
28 |
| 2025-Q4 | Increased | 1.8M | +0.1% | $14.2M | 0.0% | $7.66 | 28 |
| 2025-Q3 | Decreased | 1.8M | -0.0% | $13.8M | 0.0% | $7.55 | 0 |
| 2025-Q2 | Decreased | 1.8M | -0.8% | $16.3M | 0.0% | $9.36 | 0 |
| 2025-Q1 | Decreased | 1.8M | -0.3% | $13.8M | 0.0% | $7.86 | 0 |
| 2024-Q4 | Decreased | 1.8M | -0.0% | $13.9M | 0.0% | $7.53 | 0 |
| 2024-Q3 | Decreased | 1.8M | -0.0% | $14M | 0.0% | $7.62 | 0 |
| 2024-Q2 | Decreased | 1.8M | -0.0% | $11.4M | 0.0% | $6.18 | 0 |